Search Results - Tooru Shimosegawa
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Effects of ALDH2 genotype, PPI treatment and L-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration. by Ryuhei Maejima, Katsunori Iijima, Pertti Kaihovaara, Waku Hatta, Tomoyuki Koike, Akira Imatani, Tooru Shimosegawa, Mikko Salaspuro
Published in PLoS ONE (2015-01-01)Get full text
Article -
9
A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis by Katsuya Endo, Motoyuki Onodera, Hisashi Shiga, Masatake Kuroha, Tomoya Kimura, Keiichiro Hiramoto, Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa
Published in Gastroenterology Research and Practice (2016-01-01)Get full text
Article -
10
The Effectiveness of Self-Expandable Metallic Stent Insertion in Treating Right-Sided Colonic Obstruction: A Comparison between SEMS and Decompression Tube Placement and an Investi... by Rintaro Moroi, Katsuya Endo, Ryo Ichikawa, Hiroshi Nagai, Hirohiko Shinkai, Tomoya Kimura, Fumitake Ishiyama, Kei Yaguchi, Shoichi Kayaba, Tooru Shimosegawa
Published in Gastroenterology Research and Practice (2014-01-01)Get full text
Article -
11
Plasma L-cystine/L-glutamate imbalance increases tumor necrosis factor-alpha from CD14+ circulating monocytes in patients with advanced cirrhosis. by Eiji Kakazu, Yoshiyuki Ueno, Yasuteru Kondo, Jun Inoue, Masashi Ninomiya, Osamu Kimura, Yuta Wakui, Koji Fukushima, Keiichi Tamai, Tooru Shimosegawa
Published in PLoS ONE (2011-01-01)Get full text
Article -
12
Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease. by Hirofumi Chiba, Yoichi Kakuta, Yoshitaka Kinouchi, Yosuke Kawai, Kazuhiro Watanabe, Munenori Nagao, Takeo Naito, Motoyuki Onodera, Rintaro Moroi, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Hisashi Shiga, Katsuya Endo, Kenichi Negoro, Masao Nagasaki, Michiaki Unno, Tooru Shimosegawa
Published in PLoS ONE (2019-01-01)Get full text
Article -
13
1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial. by Yasuteru Kondo, Takanobu Kato, Osamu Kimura, Tomoaki Iwata, Masashi Ninomiya, Eiji Kakazu, Masahito Miura, Takehiro Akahane, Yutaka Miyazaki, Tomoo Kobayashi, Motoyasu Ishii, Norihiro Kisara, Kumiko Sasaki, Haruo Nakayama, Takehiko Igarashi, Noriyuki Obara, Yoshiyuki Ueno, Tatsuki Morosawa, Tooru Shimosegawa
Published in PLoS ONE (2013-01-01)Get full text
Article
